Financials

  • Market Capitalization 1.94 B
  • Employee 87
  • Founded 2018
  • CEO N/A
  • Website www.tyra.bio
  • Headquarter Delaware, United States
  • FIGI BBG00RCQD9D1
  • Industry 生物技术
总收入
净利润
每股基本收益(基本 EPS)
总债务
自由现金流
现金及现金等价物
市盈率
-13.08
市销率

Related tickers

#姓名价格24小时 %7天 %一个月 %一年 %市值最近7天
2013
ATAI
AtaiBeckley Inc. - Common Stock
5.51 USD+10.87%+9.11%+38.10%+39.49%2.03 B USD
2016
URGN
UroGen Pharma Ltd. - Ordinary Shares
39.80 USD+0.73%+2.98%+34.69%+109.47%1.94 B USD
2041
GLUE
Monte Rosa Therapeutics, Inc. - Common Stock
22.65 USD+3.05%-6.75%+21.84%+100.44%1.91 B USD
2051
NTLA
Intellia Therapeutics, Inc. - Common Stock
13.32 USD+2.30%-22.20%+4.23%-2.92%1.86 B USD

新闻